Found: 24
Select item for more details and to access through your institution.
Cardiac outcomes of trastuzumab therapy in patients with HER2-positive breast cancer and reduced left ventricular ejection fraction.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 1, p. 239, doi. 10.1007/s10549-019-05139-6
- By:
- Publication type:
- Article
Two-Dimensional Speckle Tracking Echocardiography Detects Subclinical Left Ventricular Systolic Dysfunction among Adult Survivors of Childhood, Adolescent, and Young Adult Cancer.
- Published in:
- BioMed Research International, 2016, v. 2016, p. 1, doi. 10.1155/2016/9363951
- By:
- Publication type:
- Article
Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipients.
- Published in:
- European Heart Journal, 2023, v. 44, n. 22, p. 2029, doi. 10.1093/eurheartj/ehad117
- By:
- Publication type:
- Article
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement.
- Published in:
- European Heart Journal, 2022, v. 43, n. 4, p. 280, doi. 10.1093/eurheartj/ehab674
- By:
- Publication type:
- Article
Association of Pulse Pressure With Cardiovascular Outcome Is Independent of Left Ventricular Hypertrophy and Systolic Dysfunction: The Strong Heart Study
- Published in:
- American Journal of Hypertension, 2006, v. 19, n. 6, p. 601, doi. 10.1016/j.amjhyper.2005.12.009
- By:
- Publication type:
- Article
Left Atrial Systolic Force and Cardiovascular Outcome: The Strong Heart Study
- Published in:
- American Journal of Hypertension, 2005, v. 18, n. 12, p. 1570, doi. 10.1016/j.amjhyper.2005.05.036
- By:
- Publication type:
- Article
Left Atrial Systolic Force and Cardiac Markers of Preclinical Disease in Hypertensive Patients: The Hypertension Genetic Epidemiology Network (HyperGEN) Study
- Published in:
- American Journal of Hypertension, 2005, v. 18, n. 7, p. 899, doi. 10.1016/j.amjhyper.2005.01.005
- By:
- Publication type:
- Article
Association of inappropriate left ventricular mass with systolic and diastolic dysfunction: The HyperGEN study
- Published in:
- American Journal of Hypertension, 2004, v. 17, n. 9, p. 828, doi. 10.1016/j.amjhyper.2004.04.008
- By:
- Publication type:
- Article
Impact of blood pressure on cardiac structure and cardiovascular outcome in the metabolic syndrome: the strong heart study
- Published in:
- 2003
- By:
- Publication type:
- Abstract
ATPIII-defined metabolic syndrome is associated with prevalence of LV hypertrophy in white, but not in African American, treated hypertensives: the hypergen study
- Published in:
- 2003
- By:
- Publication type:
- Abstract
Prevalence and correlates of aortic valve sclerosis in hypertensive adults: the hypergen study
- Published in:
- 2003
- By:
- Publication type:
- Abstract
Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Relation of left ventricular hypertrophy to inflammation and albuminuria in adults with type 2 diabetes: the strong heart study.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Nomogram for Predicting Risk of Cancer Therapy-Related Cardiac Dysfunction in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.
- Published in:
- Journal of the American Heart Association, 2023, v. 12, n. 19, p. 1, doi. 10.1161/JAHA.123.029465
- By:
- Publication type:
- Article
Reduced cardiorespiratory fitness in adult survivors of childhood acute lymphoblastic leukemia.
- Published in:
- Pediatric Blood & Cancer, 2013, v. 60, n. 8, p. 1358, doi. 10.1002/pbc.24492
- By:
- Publication type:
- Article
Expect the unexpected: fulminant myocardial cytotoxic Injury from Trabectedin.
- Published in:
- Cardio-Oncology, 2024, v. 10, n. 1, p. 1, doi. 10.1186/s40959-024-00257-7
- By:
- Publication type:
- Article
Rationale and design of a cardiac safety study for reduced cardiotoxicity surveillance during HER2-targeted therapy.
- Published in:
- Cardio-Oncology, 2023, v. 9, n. 1, p. 1, doi. 10.1186/s40959-023-00163-4
- By:
- Publication type:
- Article
Differentiation syndrome-induced Myopericarditis in the induction therapy of acute Promyelocytic leukemia: a case report.
- Published in:
- Cardio-Oncology, 2021, v. 7, n. 1, p. 1, doi. 10.1186/s40959-021-00124-9
- By:
- Publication type:
- Article
Cardiac Safety of Dual Anti-HER2 Therapy in the Neoadjuvant Setting for Treatment of HER2-Positive Breast Cancer.
- Published in:
- Oncologist, 2017, v. 22, n. 6, p. 642, doi. 10.1634/theoncologist.2016-0406
- By:
- Publication type:
- Article
Cardiac Safety of Paclitaxel Plus Trastuzumab and Pertuzumab in Patients With HER2-Positive Metastatic Breast Cancer.
- Published in:
- Oncologist, 2016, v. 21, n. 4, p. 418, doi. 10.1634/theoncologist.2015-0321
- By:
- Publication type:
- Article
Continuous Trastuzumab Therapy in Breast Cancer Patients With Asymptomatic Left Ventricular Dysfunction.
- Published in:
- Oncologist, 2015, v. 20, n. 10, p. 1105, doi. 10.1634/theoncologist.2015-0125
- By:
- Publication type:
- Article
Cost-Effectiveness of Screening for Asymptomatic Left Ventricular Dysfunction in Childhood Cancer Survivors.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Cardiovascular Care of the Oncology Patient During COVID-19: An Expert Consensus Document From the ACC Cardio-Oncology and Imaging Councils.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Cardio‐oncology care in the era of the coronavirus disease 2019 (COVID‐19) pandemic: An International Cardio‐Oncology Society (ICOS) statement.
- Published in:
- CA: A Cancer Journal for Clinicians, 2020, v. 70, n. 6, p. 480, doi. 10.3322/caac.21635
- By:
- Publication type:
- Article